The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft
ContributorsBeauverd, Yan; Morin, Sarah; Stephan, Caroline; De Ramon Ortiz, Carmen Julia; Fabra Urdiola, Marta; Giannotti, Federica; Mahne, Elif; Mamez, Anne-Claire; Mappoura, Maria; Simonetta, Federico; Tran, Thien-An; Ayer, Christian; Noetzlin, Sarah Audrey; Verdon, Isaline; Masouridi Levrat, Stavroula; Chalandon, Yves
Published inBone marrow transplantation, vol. 56, no. 9, p. 2284-2286
Publication date2021-09
First online date2021-05-18
Keywords
- Cytogenetic Analysis
- Graft vs Host Disease
- Hematopoietic Stem Cell Transplantation
- Humans
- Leukemia, Myeloid, Acute / genetics
- Leukemia, Myeloid, Acute / therapy
- Prognosis
- Retrospective Studies
- Risk Factors
- T-Lymphocytes
Affiliation
Citation (ISO format)
BEAUVERD, Yan et al. The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft. In: Bone marrow transplantation, 2021, vol. 56, n° 9, p. 2284–2286. doi: 10.1038/s41409-021-01334-6
Main files (1)
Article (Published version)
Identifiers
- PID : unige:160536
- DOI : 10.1038/s41409-021-01334-6
- PMID : 34007052
ISSN of the journal0268-3369
